Evidence map›Paper›PMID 39545473›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2025

Cognitive Function in Individuals with Chronic Hypoparathyroidism-A Prospective Observational Study.

Adelina Tmava-Berisha, Astrid Fahrleitner-Pammer, Tatjana Stross, Simon Geiger, Christina Geiger, Frederike Fellendorf, Mario Scherkl, Alexander Finner, Anna Holl, Nina Dalkner and 2 more

Abstract readObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adelina Tmava-BerishaDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Astrid Fahrleitner-PammerDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
Tatjana StrossDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Simon GeigerDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
Christina GeigerDivision of Infectiology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
Frederike FellendorfDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Mario ScherklDivision of Pediatric Radiology, Department of Radiology, Medical University of Graz, 8036 Graz, Austria.
Alexander FinnerDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Anna HollDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Nina DalknerDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Eva ReininghausDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Karin AmreinDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0003-0915-085X

Funding

ShireTakeda
6 · The paper itself

Abstract

objective"Brain fog" is a frequently reported, distressing experience among individuals with chronic hypoparathyroidism, characterized by reduced concentration and reduced ability to perform day-to-day tasks. However, evidence linking chronic hypoparathyroidism to cognitive impairment is limited and inconsistent. This study aimed to explore cognitive function in these patients using a validated neurocognitive test battery, compare results with a matched healthy control group, and analyze the frequency of cognitive impairment based on normative data.

methodsThe participants' cognitive performance was tested using a cognitive test battery, including the Trail Making Test A/B, the Color-Word Interference Test, and the California Verbal Learning Test. These tests were used to evaluate the cognitive domains of attention and processing speed, verbal learning and memory, and executive function. In total, 30 individuals with hypoparathyroidism and 30 healthy controls were included.

resultsTwenty-four patients were women (80.0%), with a median age of 44.5 ± 13.1 and a median disease duration of 8.7 years (±5.3). Individuals with chronic hypoparathyroidism showed poorer cognitive performance in attention and processing speed [F(1,57) = 8.65, P = .005*, η2 = 0.13] compared to healthy controls. A significantly higher percentage of patients had cognitive deficits in both attention and processing speed (56.7% vs 3.3%) and executive function (60.0% vs 16.7%).

conclusionThis study provides evidence that cognitive dysfunction, particularly in attention and processing speed, is common in chronic hypoparathyroidism. Recognizing cognitive impairment in these patients is crucial, especially when discussing workability. Neuropsychological training as an adjunct therapy strategy may be beneficial in managing these cognitive deficits.

Indexed as

CognitionCognitive DysfunctionHypoparathyroidismAdultAttentionCase-Control StudiesChronic DiseaseExecutive FunctionFemaleHumansMaleMiddle AgedNeuropsychological TestsProspective Studiescognitive functionhypoparathyroidismneuropsychological test batteryparathormone

Identifiers

PMID39545473
PMCPMC12261092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.